Showing results (661-670 of 784) with videos related to
Sort By:
Pageof 79
Genome Biology|November 2, 2016
Capture Hi-C identifies a novel causal gene, IL20RA, in the pan-autoimmune genetic susceptibility region 6q23Amanda McGovern, Stefan Schoenfelder, Paul Martin, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2025
Comparative Effectiveness of Abatacept versus Adalimumab in Shared Epitope positive and negative Rheumatoid Arthritis patientsChuan Fu Yap, Nisha Nair, Seema D Sharma, et al.Cerebral Circulation - Cognition and Behavior|November 3, 2022
What does aducanumab treatment of Alzheimer's disease mean for research on vascular cognitive disorders?Anders Wallin, Suvarna Alladi, Sandra E Black, et al.Cancer Research|January 7, 2006
Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and functionS Lilly Zheng, Jeong-ho Ju, Bao-li Chang, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2010
Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II studyJose M Gatell, Christine Katlama, Beatriz Grinsztejn, et al.Arthritis Research & Therapy|December 17, 2005
Analysis of Fcgamma receptor haplotypes in rheumatoid arthritis: FCGR3A remains a major susceptibility gene at this locus, with an additional contribution from FCGR3BAnn W Morgan, Jennifer H Barrett, Bridget Griffiths, et al.Blood|October 24, 2002
Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritisFrederique Ponchel, Ann W Morgan, Sarah J Bingham, et al.Trials|May 24, 2017
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trialMathilde M H Pauls, Natasha Clarke, Sarah Trippier, et al.The Prostate|March 26, 2008
Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African AmericansJielin Sun, Lina Purcell, Zhengrong Gao, et al.BMC Cancer|June 14, 2024
Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort studyAbigail Gault, Linda Hogarth, Kristian C Williams, et al.Pageof 79